Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease

被引:3
|
作者
De, Tanima [1 ]
Zhang, Honghong [1 ]
Alarcon, Cristina [1 ]
Lec, Bianca [1 ]
Avitia, Juan [1 ]
Smithberger, Erin [2 ]
Chen, Chuyu [1 ]
Horvath, Minnie [1 ]
Kwan, Sara [3 ]
Young, Mary [3 ]
Adhikari, Sarbani [3 ]
Kwon, John [2 ]
Pacheco, Jennifer [1 ]
Jarvik, Gail [4 ,5 ]
Wei, Wei-Qi [6 ]
Mentch, Frank [7 ]
Hakonarson, Hakon [7 ,8 ]
Sleiman, Patrick [7 ,8 ]
Gordon, Adam [1 ]
Harley, John [9 ,10 ]
Linneman, Jim [11 ]
Hebbring, Scott [12 ]
Parisiadou, Loukia [1 ]
Perera, Minoli A. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA
[6] Vanderbilt Univ, Med Ctr, Biomed Informat, Nashville, TN USA
[7] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
[8] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA
[10] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[11] Marshfield Clin Res Inst, Off Res Comp & Analyt, Marshfield, WI USA
[12] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA
来源
PHARMACOGENETICS AND GENOMICS | 2022年 / 32卷 / 01期
关键词
anti-TNF alpha; genome-wide association study; inflammatory bowel disease; primary nonresponse; single-nucleotide polymorphism; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; MANIFESTATIONS; POLYMORPHISMS; VARIANTS; DRUG; METAANALYSIS; IMPUTATION;
D O I
10.1097/FPC.0000000000000445
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Primary nonresponse (PNR) to antitumor necrosis factor-alpha (TNF alpha) biologics is a serious concern in patients with inflammatory bowel disease (IBD). We aimed to identify the genetic variants associated with PNR. Patients and methods Patients were recruited from outpatient GI clinics and PNR was determined using both clinical and endoscopic findings. A case-control genome-wide association study was performed in 589 IBD patients and associations were replicated in an independent cohort of 293 patients. Effect of the associated variant on gene expression and TNF alpha secretion was assessed by cell-based assays. Pleiotropic effects were investigated by Phenome-wide association study (PheWAS). Results We identified rs34767465 as associated with PNR to anti-TNF alpha therapy (odds ratio: 2.07, 95% CI, 1.46-2.94, P = 2.43 x 10(-7), [replication odds ratio: 1.8, 95% CI, 1.04-3.16, P = 0.03]). rs34767465 is a multiple-tissue expression quantitative trait loci for FAM114A2. Using RNA-sequencing and protein quantification from HapMap lymphoblastoid cell lines (LCLs), we found a significant decrease in FAM114A2 mRNA and protein expression in both heterozygous and homozygous genotypes when compared to wild type LCLs. TNF alpha secretion was significantly higher in THP-1 cells [differentiated into macrophages] with FAM114A2 knockdown versus controls. Immunoblotting experiments showed that depletion of FAM114A2 impaired autophagy-related pathway genes suggesting autophagy-mediated TNF alpha secretion as a potential mechanism. PheWAS showed rs34767465 was associated with comorbid conditions found in IBD patients (derangement of joints [P = 3.7 x 10(-4)], pigmentary iris degeneration [P = 5.9 x 10(-4)], diverticulum of esophagus [P = 7 x 10(-4)]). Conclusions We identified a variant rs34767465 associated with PNR to anti-TNF alpha biologics, which increases TNF alpha secretion through mechanism related to autophagy. rs34767465 may also explain the comorbidities associated with IBD.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Sara T. Campos
    Francisco A. Portela
    Luís Tomé
    International Journal of Colorectal Disease, 2017, 32 : 645 - 650
  • [32] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease
    Theodoraki, Eirini
    Orfanoudaki, Eleni
    Foteinogiannopoulou, Kalliopi
    Andreou, Nikolaos-Panagiotis
    Gazouli, Maria
    Koutroubakis, Ioannis E.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (03) : 639 - 646
  • [33] EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
    Mitchel, Elana
    Huang, Jing
    Zemel, Babette
    Baldassano, Robert
    Albenberg, Lindsey
    Denburg, Michelle
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S19 - S19
  • [34] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Huang, Yu-hong
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E156 - E156
  • [35] EXCESSIVE WEIGHT GAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ON ANTI-TNF THERAPY
    Mitchel, Elana
    Huang, Jing
    Zemel, Babette
    Baldassano, Robert
    Albenberg, Lindsey
    Denburg, Michelle
    GASTROENTEROLOGY, 2021, 160 (03) : S24 - S25
  • [36] Elderly patients with inflammatory bowel disease under anti-TNF therapy: efficacy and safety
    Ortega, T. Lobaton
    Vermeire, S.
    Ballet, V.
    Rutgeerts, P.
    Van Assche, G.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S273 - S273
  • [37] Is Anti-TNF Therapy Always Prohibited in Patients with Inflammatory Bowel Disease and Previous Malignancy?
    Lust, Mark
    Travis, Simon
    PRACTICAL GASTROENTEROLOGY, 2009, 33 (08) : 25 - 30
  • [38] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease
    Eirini Theodoraki
    Eleni Orfanoudaki
    Kalliopi Foteinogiannopoulou
    Nikolaos-Panagiotis Andreou
    Maria Gazouli
    Ioannis E. Koutroubakis
    International Journal of Colorectal Disease, 2022, 37 : 639 - 646
  • [39] Anti-TNF therapy is safe and beneficial in Inflammatory Bowel Disease patients with Liver Transplantation
    Shastri, Nikhil
    Venu, Nanda
    Zadvornova, Yelena
    Stein, Daniel
    Perera, Lilani
    Saeian, Kia
    Naik, Amar
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S41 - S41
  • [40] Anti-TNF Treatment in Inflammatory Bowel Disease
    Yapali, Suna
    Hamzaoglu, Hulya Over
    ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53